We are live on ! Find out more
SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

175 hedge funds and large institutions have $374M invested in Sage Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $3.95M | Put options by funds: $1.55M

29% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 51

4.69% less ownership

Funds ownership: 88.92%84.24% (-4.7%)

9% less funds holding

Funds holding: 193175 (-18)

36% less capital invested

Capital invested by funds: $581M → $374M (-$207M)

55% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 33

Holders
175
Holders Change
-18
Holders Change %
-9.33%
% of All Funds
2.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
66
Reduced
51
Closed
33
Calls
$3.95M
Puts
$1.55M
Net Calls
+$2.4M
Net Calls Change
-$5.52M
Name Holding Trade Value Shares
Change
Change in
Stake
HT
201
Headlands Technologies
Illinois
-$42.5K -3,916 Closed
DB
202
Danske Bank
Denmark
-$37.3K -3,434 Closed
Pacer Advisors
203
Pacer Advisors
Pennsylvania
-$7.61K -701 Closed
LC
204
Lindbrook Capital
California
-$4.99K -459 Closed
PWMG
205
Private Wealth Management Group
New Jersey
-$1.03K -95 Closed
AA
206
Ancora Advisors
Ohio
-$814 -75 Closed
C
207
Covestor
United Kingdom
-$9 -1 -14%
HWM
208
Hemington Wealth Management
Virginia
+$73 +8 New